RIPK4 and melanoma: Thus, RIPK4/NF-κB-dependent signaling axis at least partly sustains mesenchymal phenotype of melanoma cells as additionally revealed by morphological shifts of WM266.4 cells towards an epithelioid phenotype upon RIPK4 inhibition.